Our research efforts will center on the possible cellular mechanisms of hepatocyte transformation focusing on the hypothesis that the insulin receptor substrate-1 (IRS-1) pathway activation in HCC provides the stimulus for constitutive hepatocyte proliferation; it is in this milieu that other secondary events, i.e., cellular injury, cirrhosis and/or genetic mutation(s), may occur leading/contributing to subsequent tumor development. Prior studies demonstrate overexpression of IRS-1, or activation of this insulin/IGF-1 stimulated growth pathway(s) in 95 percent of human HCC tumors (compared to adjacent uninvolved normal liver) representing the most common cellular event described thus far. In vivo and in vitro studies of downstream genes upregulated by IRS-1 overexpression have begun to be defined, and we postulate that human aspartyl (asparaginyl) beta hydroxylase (HAAH) may be important in tumor pathogenesis with expression and function apparently linked to the IRS-1 signal transduction cascade. It is known that IRS-1 overexpression produces hepatocyte proliferation, malignant transformation of NIH 3T3 cells, and inhibits TGF-beta1 induced programmed cell death of hepatocytes. If HAAH is a downstream effector gene in this pathway, it will be important to: 1] establish a connection between IRS-1 and HAAH gene upregulation. In this regard HAAH expression levels on malignant phenotype generation will be studied. To determine possible molecular mechanisms FOCUS HCC, NIH 3T3 and 32D cells will be stably transfected with dominant-negative IRS-1 cDNAs mutated in the plextrin and phosphotryosine (PTB) domains, and Grb2, Syp and P13K binding motifs located in the C-terminus of the protein. 2] Evaluate the biologic consequences of increased HAAH expression with respect to acquisition of cellular resistance to apoptosis, alteration of phenotype leading to increased invasive growth, and enhanced cellular proliferation. 3] Finally, we will examine the hypothesis that initiation of a second cellular event(s) leads to HCC development in vivo. A unique transgenic mouse model will be used for IRS-1 expression which produces a nontransforming, but continuous, hepatocyte proliferative stimulus. Secondary events will be introduced through breeding of the IRS-1 transgenic mouse with p53 knockout mice, Hbx transgenic mice, and initiation of acute/chronic cellular injury and cirrhosis by intraperitoneal injection of thioacetamide. The IRS-1 transgenic model may provide an ideal cellular milieu in which the influence of secondary genetic events completing the in vivo hepatocytic transformation process may be studied.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37CA035711-17
Application #
6191327
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Read-Connole, Elizabeth Lee
Project Start
1983-07-01
Project End
2005-06-30
Budget Start
2000-07-01
Budget End
2001-06-30
Support Year
17
Fiscal Year
2000
Total Cost
$318,000
Indirect Cost
Name
Rhode Island Hospital (Providence, RI)
Department
Type
DUNS #
161202122
City
Providence
State
RI
Country
United States
Zip Code
02903
Tsedensodnom, Orkhontuya; Koga, Hironori; Rosenberg, Stephen A et al. (2011) Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. Exp Cell Res 317:920-31
Walker, Evan J; Rosenberg, Stephen A; Wands, Jack R et al. (2011) Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma. For Immunopathol Dis Therap 2:195-204
von dem Bussche, Annette; Machida, Raiki; Li, Ke et al. (2010) Hepatitis C virus NS2 protein triggers endoplasmic reticulum stress and suppresses its own viral replication. J Hepatol 53:797-804
He, Jiman; de la Monte, Suzanne; Wands, Jack R (2010) The p85beta regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling. Biochem Biophys Res Commun 397:513-9
Toyama, Takashi; Lee, Han Chu; Koga, Hironori et al. (2010) Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration. Mol Cancer Res 8:254-65
Tsai, Adrienne; Kawai, Shigenobu; Kwei, Karen et al. (2009) Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations. Virology 387:364-72
Longato, Lisa; de la Monte, Suzanne; Kuzushita, Noriyoshi et al. (2009) Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver. Hepatology 49:1935-43
Gehring, Stephan; Gregory, Stephen H; Wintermeyer, Philip et al. (2009) Generation of immune responses against hepatitis C virus by dendritic cells containing NS5 protein-coated microparticles. Clin Vaccine Immunol 16:163-71
Laperle, Christopher M; Hamilton, Theron J; Wintermeyer, Philip et al. (2008) Low density contrast agents for x-ray phase contrast imaging: the use of ambient air for x-ray angiography of excised murine liver tissue. Phys Med Biol 53:6911-23
Kim, Eun; Li, Ke; Lieu, Charmiane et al. (2008) Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis. J Hepatol 49:787-98

Showing the most recent 10 out of 189 publications